Printer Friendly

PFIZER COMPLETES SALE OF PLAX INTERNATIONAL

 PFIZER COMPLETES SALE OF PLAX INTERNATIONAL
 NEW YORK, Dec. 17 /PRNewswire/ -- Pfizer Inc (NYSE: PFE) announced


today that it has sold its Plax International anti-plaque mouthwash business to Colgate-Palmolive (NYSE: CL). Plax International, with sales of about $70 million in 35 countries, was sold for $105 million in cash. The agreement was announced Oct. 28.
 Pfizer expects that this transaction will not have a significant impact on the financial statements of Pfizer.
 Pfizer Inc is a diversified, research-based health care company with businesses in pharmaceuticals, hospital products, consumer products, animal health and specialty chemicals and minerals. The company reported sales of more than $6.4 billion for 1990. In addition to Plax, which Pfizer will continue to market in the United States, Canada and Puerto Rico, Pfizer markets such other well-known consumer products as Visine, Ben-Gay, Unisom, Desitin, Rid, Barbasol and Coty.
 -0- 12/17/91
 /CONTACT: Brian McGlynn of Pfizer, 203-441-5448/
 (PFE CL) CO: Pfizer Inc; Colgate-Palmolive ST: New York IN: MTC SU: TNM


SH-OS -- NY070 -- 3074 12/17/91 15:36 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 17, 1991
Words:174
Previous Article:NUEVO ENERGY ANNOUNCES A TEST ON THE PROVOST CYR NO. 2 OF OVER 1,000 BARRELS OF OIL PER DAY
Next Article:ROBINSON PLANT CITED FOR NRC VIOLATION
Topics:


Related Articles
PFIZER REPORTS NET INCOME GROWTH OF 14 PERCENT ON A 4 PERCENT SALES GAIN IN SECOND QUARTER
EMERGENCY DONATION OF PFIZER PRODUCTS DISTRIBUTED TO VICTIMS OF HURRICANE ANDREW
CLEMENTE TO HEAD NEW CORPORATE AFFAIRS DIVISION AT PFIZER; MILLER RESPONSIBLE FOR LEGAL DIVISION
PROPERTY PURCHASE WILL ALLOW PFIZER TO EXPAND IN PARSIPPANY, N.J.
PFIZER'S 'UNDERLYING STRENGTH' LED TO EXCELLENT RESULTS FOR 1993, STEERE REPORTS TO SHAREHOLDERS
NETHERLANDS REGULATORS APPROVE ENABLEX
Pfizer Inc: New Product Success Foundation for Strong International and U.S. Growth, Company Tells Analysts
Pfizer Completes Sale of Howmedica to Stryker Corporation.
FTC Grants Final Clearance for Pfizer/Warner-Lambert Merger, Transaction Completed Today.
Pfizer Animal Health Agrees to Acquire Embrex, Inc., the Leader in 'In Ovo' Poultry Vaccine-Delivery Technology.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters